Daily Roundup

CLG.ASX ATG.ASX MAP.ASX ALC.ASX SMP.ASX

Close the Loop Ltd Provides Market Update

Close the Loop Limited, the circular economy industry leader, has provided a market update including its cash and debt position at 30 June 2025 and the appointment of a new CEO for its North American operations. The company continues to make meaningful progress in addressing many of the key issues impacting its FY25 financial performance, with steady improvements expected to lead to ongoing operational efficiencies over the next 12 months.

Revenue and earnings before interest, tax, depreciation and amortisation (EBITDA) for the financial year ending 30 June 2026 (FY26) are expected to increase because of the continuous improvements that the company is expected to realise in the 2026 financial year. The company has also secured several new opportunities during the 2025 financial year, which are expected to drive an increase in revenue for FY26.

The company has formally appointed Matthew Zimmer as its new Chief Executive Officer for its North American refurbishment and ITAD operations, an accomplished executive with extensive domestic and international experience including ITAD operations.

The company remains focused on building momentum and sustaining its positive trajectory as it works toward delivering stronger financial outcomes and long-term value.

Articore Group reinforces governance and strategy

Articore Group reaffirms its commitment to strong corporate governance, disciplined strategic execution and shareholder value creation. The Board recognizes shareholder rights and is open to constructive engagement, while ensuring a well-functioning, independent and appropriately skilled board is maintained.

The Board is committed to ensuring it has the optimal mix of experience, diversity and market-aligned expertise to steward Articore's growth. A strategic review, as announced on 11 June 2025, is progressing, and Articore will keep all shareholders updated on any material developments.

Microba Life Sciences Requests Suspension Pending Capital Raise

Microba Life Sciences Ltd has requested a voluntary suspension of its securities on the ASX, pending the announcement of a proposed capital raise. The suspension is expected to be lifted by Tuesday, 24 June 2025.

Microba secures $14.5 million to drive clinical adoption

Microba Life Sciences Ltd has successfully secured $14.5 million in funding to drive expanded clinical adoption of its core microbiome testing products, with support from existing and new investors including Sonic Healthcare Limited.

The funds raised will be used to drive expanded clinical adoption of the company's core microbiome testing products, with a focus on advancing the product development roadmap, scaling sales and commercial operations, and developing targeted clinical evidence.

Microba has narrowed its FY25 revenue guidance to $15.4 - $16 million and expects to achieve regional break-even points in Australia and the United Kingdom by the end of FY26, with a strategic objective to target group breakeven in approximately 3 years.

Microba Life Sciences Ltd Reinstated to ASX Quotation

Microba Life Sciences Ltd (ASX: MAP) has been reinstated to trading on the Australian Securities Exchange (ASX) after a period of suspension, following the release of an announcement regarding a capital raising.

Alcidion Upgrades FY25 EBITDA Guidance

Alcidion Group Ltd has upgraded its FY25 EBITDA guidance to exceed $4.5 million, driven by contract upgrades, extensions, cost management, and favourable FX movements. The company continues to see new opportunities, both with existing and new customers, providing confidence in the longer-term value proposition of Alcidion and its ability to address the critical challenges faced by hospital systems globally.

Smartpay enters into Scheme Implementation Agreement

Smartpay Holdings Ltd has entered into a Scheme Implementation Agreement with Shift4 Payments, LLC to acquire all Smartpay shares for NZ$1.20 per share in cash, representing a 46.5% premium to the 90-day VWAP.

Smartpay Holdings Ltd to be acquired by Shift4 Payments, LLC

Smartpay Holdings Ltd and Shift4 Payments, LLC have entered into a Scheme Implementation Agreement for Shift4 Payments to acquire all Smartpay shares for NZ$1.20 per share, subject to various conditions including regulatory, shareholder and court approvals.